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Abstract
Objective This study analyses the diagnostic potential of
Diffusion-Weighted Imaging with Background Suppression
(DWIBS) in the detection of focal bone marrow lesions
from multiple myeloma. The signal and contrast properties
of DWIBS are evaluated in correlation with the serum
concentration of M-component (MC) and compared with
established T1- and T2-weighted sequences.
Methods Data from 103 consecutive studies in 81 patients are
analysed retrospectively. Signal intensities and apparent
Diffusion Coefficients (ADC) of 79 focal lesions in the
lumbar spine or pelvis of 38 patients are determined and
contrast-to-noise-ratio (CNR) is calculated. Data from patients
with low (<20 g/L) and high (>20 g/dL) MC are evaluated
separately.
Results Signal intensities of focal myeloma lesions on
T2w-STIR vary significantly depending on the MC, which
leads to a loss in CNR in patients with high MC. No signal
variation is observed for T1w-TSE and DWIBS. The CNR
values provided by DWIBS in patients with high MC are
slightly higher than those of T2w-STIR. ADC values in
patients with low MC are significantly higher than in
patients with high MC.
Conclusion Whole-body DWIBS has the potential to im-
prove the conspicuity of focal myeloma lesions and provides
additional biological information by ADC quantification.
Keywords Multiple myeloma .Whole-body MRI .
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Introduction
Although conventional radiography is still the standard
staging procedure for newly diagnosed and relapsed multiple
myeloma (MM) patients in clinical routine, whole-body MRI
(WB-MRI) using T1- and T2-weighted contrast-enhanced
images has provided evidence of its advantages over
conventional skeletal survey [1]. It provides important
complementary information as, for example, osteoporosis
may be a sign of tumour infiltration, but is difficult to
distinguish from senile osteoporosis on conventional radio-
graphs. Also an extramedullary tumour extension could be
missed on x-ray images, but is easily detected by means of
MRI [2]. Whole-body MRI is therefore recommended at
least in MM patients with normal conventional radiography
and in all patients with an apparent solitary plasmocytoma of
the bone [3]. It must be highlighted that a limited MR
examination restricted to spinal and pelvic bone marrow may
be inferior to radiographic skeletal survey, whereas whole-
body MRI has been demonstrated to be superior to skeletal
survey and also to computed tomography [4, 5].
There is some evidence that disease burden in patients
with MM can even be quantified by MRI. The extent of
bone marrow involvement determined by WB-MRI corre-
lates with other conventional parameters of disease and
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may independently predict survival in patients with MM at
the time of initial diagnosis [6].
The key imaging criterion for the staging of multiple
myeloma according to the Durie-and-Salmon-plus classifi-
cation is the number of detectable focal lesions on skeletal
survey [7]. With MRI, focal bone marrow involvement is
best detected through the use of Turbo Spin-Echo (TSE)
Short TI Inversion Recovery (STIR) sequences. Unen-
hanced T1-weighted SE images are superior in the case of
diffuse infiltration, and sensitivity for detecting diffuse
infiltration can be increased by signal intensity measure-
ments after contrast administration [8].
Diffusion-weighted imaging with background suppres-
sion (DWIBS) was first described by Takahara et al. in
2004 [9]. Since then, various authors have underlined the
high potential of the technique in oncological imaging [10,
11]. The inherent contrast of DWIBS—as it is used for the
detection of malignant tumour disease—is based on
increased signal intensity in tissue with restricted water
diffusivity. By this, the technique is capable to detect tissue
with increased cellularity non-invasively by measuring the
microscopic movement of water molecules [12–14].
Whole-body MRI with diffusion-weighted sequences has
been used for staging various solid tumour entities [10, 14, 15].
To date, there are no published studies using DWIBS in the
diagnostic work-up of multiple myeloma patients. This study
analyses the potential of DWIBS in MM diagnostics by
evaluating the bone-marrow-to-lesion-contrast ratio provided
by T2w-TSE and DWIBS in correlation with the serum
concentration of the M-component (MC).
Materials and methods
Patients
Data from 103 consecutive studies of 81 patients (48 men, 33
women, mean age 59 years, median age 61 years, age range 25–
86 years) were analysed retrospectively. All patients were
referred to our department with known or suspected plasma cell
disorder. No other acute malignancy was known as indicated by
the referring physicians. The patients underwent whole-body
MRI with step-wise table motion for initial staging (n=29) or
for restaging (n=74). Restaging examinations comprised
follow-up studies with prior treatment in 54 cases and without
treatment in 20 cases. All procedures were in accordance with
the ethical standards of the World Medical Association. The
requirements of the local ethics committee were fulfilled.
Imaging protocol
All examinations were performed on a 1.5 T whole-body
MRI scanner (Magnetom Avanto, Siemens Healthcare.
Erlangen, Germany) using a dedicated 18-channel coil
array system (Total imaging matrix (Tim), Siemens Health-
care, Erlangen, Germany). The sequences used were a
coronal T1-weighted TSE (TR = 682 ms, TE = 11 ms,
matrix size = 384×269, slice thickness = 5 mm, Field of
View (FoV) = 50×50 cm2, acquisition time 1:08 min), a
coronal T2 weighted STIR (TR = 9,630 ms, TE = 87 ms,
TI = 180 ms, matrix size = 384×269, slice thickness =
5 mm, FoV = 50×50 cm2, acquisition time 2:24 min) and
a coronal or axial DWIBS (single shot Echo Planar
Imaging (ss-EPI), TR = 6,510 ms, TE = 68 ms, b = 0
and 800 s/mm2, STIR with fat suppression with TI =
180 ms, matrix size = 192×96, slice thickness = 5 mm,
FoV = 50×31 cm2, acquisition time 1:43 min). The total
acquisition time was 30 min. All data were acquired
during free breathing. No contrast agent was applied.
Data analysis
Initial image reading was done as part of the routine work
in consensus by two readers with at least 2 years experience
in musculoskeletal MRI. Study analysis consisted of signal
intensity measurements of the lesions (Sles) and of the
adjacent bone marrow (Sbm) by regions of interest (ROI) in
all cases, where focal lesions of the lumbar spine or pelvis
were reported, Apparent Diffusion Coefficients (ADC)
were determined from automatically calculated ADC maps
(linear fit to logarithmical data) using the same ROIs. A
maximum of 3 lesions per patient were analysed. Image
reading and ROI drawing was done on commercially
available workstations (eFilm 2.1.0, Merge Healthcare,
Milwaukee, WI, USA). Contrast-to-noise-ratio (CNR) was
calculated as
CNR ¼ Sles  Sbmj j
SDnoise
:
Serum concentrations of the M-component (MC), deter-
mined as part of the routine clinical work-up, were used for
biochemical correlation. Patients with time differences of
more than 5 weeks between the blood test and the MRI
examination were excluded. Mean time interval betweenMRI
and MC blood test was 9 days. The patients received no
therapy between the blood tests and the MRI examinations.
Statistical analysis
The patients were categorized into two groups based on the
MC levels, group 1 with levels <20 g/L, and group 2 with
levels >20 g/L. Mean values for signal intensities, ADC and
CNR were evaluated separately for the two subgroups. A
double-sided unpaired t-test was used to reveal differences
in ADC and CNR between the two subgroups.
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Results
Seventy-nine lesions in 38 patients were evaluated. 47
lesions were found in 24 patients from group 1 and 32
lesions in 14 patients from group 2. The mean MC from all
38 included patients was 20 g/L.
Figure 1 shows the results of the signal intensity
measurements (Sles): The values provided by the T2w-
STIR sequence vary significantly between the two subgroups
yielding lower values in patients from group 1 (316±169)
compared with group 2 (233±80) (p<0.01). No significant
difference in Sles is seen between the two groups for the
T1w-TSE (group 1: 271±74; group 2: 254±75) and the
b800-DWIBS (59±36; 63±22).
The results of the CNR calculations are shown in
Fig. 2: According to the course of the signal intensities,
significantly higher CNR values are observed in the T2w-
STIR images from group 1 (79±66) compared with those
from group 2 (34±22) (p<0.01). Again, no significant
variation is seen for the CNR values of the b800-DWIBS
(35±32; 40±20). When comparing the three sequences
with respect to their CNR, it is seen that the CNR values
provided by the T2w-STIR are significantly higher in
patients from group 1 compared with the two other
sequences (p<0.01). In patients from group 2, however,
DWIBS provides equal to higher CNR values compared
with T2w-STIR. The CNR values generated by the T1w-
TSE are generally far lower than those of the two other
sequences, but nevertheless show a significant small
variation between the two groups (8.2±7.1; 4.1±3.3)
(p<0.05).
The results of the ADC measurements are displayed in
Fig. 3: Along with the T2w-STIR signal intensities, the ADC
also varies significantly with the MC showing higher values
in patients from group 1 ([1.37±0.70]×10−3 mm2/s) than in
patients from group 2 ([1.00±0.30]×10−3 mm2/s) (p<0.01).
The images in Fig. 4 show signal alterations in a 67y
male receiving chemotherapy followed by autologous stem
cell transplant. Figure 4a–d are the initial MR imaging
work up with MC of 46.8 g/L and 80–90% plasma cell
infiltration in bone marrow biopsy. Figure 4e–h are the
Fig. 1 Measured signal intensities of focal lesions and standard
deviations depending on the serum concentration of the M-component
(MC). A significant difference in T2w-signal is seen between patients
with high and low MC (p<0.01)
Fig. 2 Contrast-to-noise-ratios of focal lesions and standard devia-
tions calculated depending on the serum concentration of the M-
component (MC). Significant differences between the two subgroups
are seen for T2w-STIR and T1w-SE that both provide less CNR in
patients with high MC (p<0.01)
Fig. 3 Mean ADCs of focal lesions and standard deviations depend-
ing on the serum concentration of the M-component (MC). A
significant difference in ADC is seen between patients with high and
low MC (p<0.01)
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follow up images 10 months after initial work up and
2 months after stem cell transplant with MC of 1.6 g/L.
Bone marrow biopsy performed 2 days later showed
hyperplastic bone marrow without plasma cell infiltration
conformable with complete remission. The displayed
lesions in the pelvis are clearly visible as hyperintense
spots on the b800 DWIBS images (inverted grey scale) at
comparable signal intensity at both time points (b) and (f).
On the T2w-STIR image, the lesions are hardly visible at
the time of the initial examination (a), but appear strongly
hyperintense at follow-up (e). The ADC values of the
lesions are accordingly low at the time of initial diagnosis
(c), when the patient’s paraprotein burden is high and
increase towards fluid-equivalent values during follow-up
(g), indicating a cystic transformation of the initially
solid tumour clusters. In Fig. 4(d and h), a combined
T1w-TSE and b800-DWIBS fusion image is displayed,
showing the colour-coded DWIBS signal merged onto the
corresponding T1-weighted image.
Figure 5 shows signal alterations in a 48 year-old man
who presented at initial diagnosis (Fig. 5a–d) with a focal
lesion in the left iliac bone, an intra spinal lesion originating
from the first lumbar vertebra with compression of the
conus medullaris, and an MC of 34 g/L. Both lesions have
an intermediate to bright signal intensity on T2w-STIR (a)
and b800-DWIBS (b) at this time point. Bone marrow
Fig. 5 Sample case of a 48-year-old man who received MR imaging
at initial diagnosis (a–d) and 8 months later, before autological stem
cell transplantation, after having been treated by chemotherapy (e–h).
Complete remission of the intra spinal mass (arrows) and an increase
in ADC and T2w-STIR signal of the iliac lesion (arrowheads) is seen
after therapy
Fig. 4 Sample case of a 67-year-old man who received MR imaging at initial diagnosis (a–d) and 10 months later, after having been treated by
chemotherapy and autological stem cell transplantation (e–h). Note the differences in T2-STIR signal behaviour and ADC at both time points
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plasma cell infiltration was found to be 40–50% in biopsy.
Follow up images (Fig. 5e–h) acquired 8 months later after
the patient had received systemic chemotherapy and
radiotherapy of the lumbar spine show a complete
remission of the spinal soft tissue mass and an increase of
the ADC of the iliac mass by ∼70% (1.12×10−3 mm2/s in
(c) to 1.94×10−3 mm2/s in (g)), accompanied by an increase
in T2w-STIR signal (e). MC at this time was 9 g/l. Bone
marrow biopsy performed after consecutive autological
stem cell transplant showed complete remission of disease.
Discussion
This study was performed in order to evaluate the
properties of Diffusion-Weighted Imaging with Background
Suppression in displaying and characterising focal skeletal
involvement in multiple myeloma.
The major result that can be derived from this study is
that the signal intensities of focal myeloma lesions in T2w-
STIR and the lesion’s ADCs are correlated with the serum
concentration of the M-component. Based on these find-
ings, we hypothesize that myeloma lesions show different
biological characteristics or appearance due to transition
from solid lesions of active disease with dense tumor cell
clusters and high MC to cystic spongiosa defects filled with
fluid or cell detritus and low MC during remission or after a
successful treatment. Our hypothesis is supported by the
significant change in T2w-STIR signal that is observed
between the two groups, indicating a higher amount of fluid
in the lesions of patients with low MC. Additionally, lower
ADC values are observed in those cases where a high
paraprotein burden and thus a high density of (malignant)
cells are present. The findings correlate well with the results
from previous studies that have evaluated the use of
diffusion-weighted MRI with ADC calculation for differ-
entiating benign from malignant vertebral abnormalities,
such as a fracture or a mass [16–18].
The change in T2w-STIR signal along with the MC seen
in our data leads to the fact that focal lesions tend to be less
clearly visible in patients with high paraprotein burden than
in patients with low MC which might have a negative
influence on the sensitivity of the MRI examination in
patients at initial diagnosis or during acute recurrence of
disease. Complementary DWIBS imaging may compensate
for this, as it provides a high lesion-to-background CNR
that is independent from the patient’s paraprotein level.
The signal provided by high b-value DWIBS showed no
significant variation with the MC. This is an unexpected
finding following the hypothesis that the lesions transform
to cyst-like structures with less restricted water diffusion
and thus a decreased DWIBS signal with decreasing MC.
The contrast provided by diffusion-weighted spin-echo-EPI
sequences at b-values of 800 s/mm2, however, is not
exclusively diffusion dependent, but is still sensitive to T2
relaxation effects, known as the T2 shine-through phenom-
enon. Because of this effect, tissues with long T2 (as fluid)
appear more hyperintense compared with those tissues that
have equal water diffusivity, but shorter T2 relaxation
times.
Despite the fact that the data evaluated provide statisti-
cally significant differences in ADC and T2w-STIR
contrast between the two subgroups, the interindividual
differences observed in our small patient collective are too
pronounced to allow for an accurate determination of the
disease burden derived from the individual MRI data.
Nevertheless, the data support the assumption that moni-
toring the lesion’s ADCs during follow-up might be useful
for estimating disease activity on an intraindividual basis in
addition to the clinical parameters. The MC cut-off value of
20 g/L that was chosen to separate the two patient groups in
our study represents a major criterion for the diagnosis of
multiple myeloma as introduced by Durie in 1986 and is
since then widely used in clinical practice as a limit for
identifying patients that have a considerable paraprotein
burden [19]. Also in our patient collective, paraprotein
levels >20 g/L were seen predominantly at initial diagnosis
or during acute recurrence of disease whereas low levels of
the M-component <20 g/L were observed in patients after
successful therapy representing a state of remission. Bone
marrow biopsy, as indicated in the sample cases in Figs. 4
and 5, may represent a more reliable marker for disease
activity in MM. However, due to its invasive character, this
technique is less often performed and therefore too little
data have been available for a systematic evaluation within
this study.
The key imaging criterion for the staging of multiple
myeloma according to the Durie-and-Salmon-plus classifi-
cation is the number of detectable focal lesions [6]. For this
reason, only focal lesions were evaluated in this study. We
did not correct the results for the effects of slight—and thus
invisible—diffuse infiltration of the bone marrow surround-
ing the focal lesions. According to previously published
studies, relevant signal changes in native MRI can be
observed only in cases of severe diffuse infiltration of the
bone marrow, even if intravenous contrast agent is
administered [20, 21]. Patients with a visible combined
focal and diffuse pattern of bone marrow infiltration were
not respected for signal, contrast and ADC calculations in
our study and no significant ADC variation of ‘normal’
bone marrow between the two subgroups was observed in
the patient collective evaluated. The changes in background
bone marrow signal that were observed in the T1w-TSE
images indicate, nevertheless, that there might be a certain
degree of diffuse bone marrow infiltration even though this
is not captured on the T2w-STIR and DWIBS images.
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Conclusion
Whole-body DWIBS imaging is a powerful tool for the
staging and follow-up of patients with multiple myeloma.
The technique allows for fast and robust whole-body
imaging with low technical and operational efforts. Adding
DWIBS sequences to whole-body staging protocols can
improve the conspicuity of focal MM lesions in patients
with newly diagnosed or recurrent disease. Additionally, it
provides information on the lesions’ biology by ADC
quantification. In this way it may serve not only as a tool
for lesion detection but also for intraindividual disease
monitoring during follow-up of myeloma patients.
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